Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01538030
Other study ID # MHST2012-03
Secondary ID
Status Completed
Phase N/A
First received February 18, 2012
Last updated August 13, 2012
Start date May 2012
Est. completion date August 2012

Study information

Verified date August 2012
Source Saint Thomas Hospital, Panama
Contact n/a
Is FDA regulated No
Health authority Panama: Ministry of Health
Study type Observational

Clinical Trial Summary

Premature rupture of membranes is an important cause of neonatal morbidity and mortality, mainly because of the complications associated with this pathology (oligohydramnios, cord compression or prolapse, infection). When rupture of the membranes occur the risk of cord compression increases but there is little evidence regarding this complication and amniotic fluid volume. The investigator's focus are the perinatal outcomes according to amniotic fluid volume (< 5 or >5).


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Gestational age between 24-34 weeks.

- Confirmed diagnosis of premature rupture of membranes.

Exclusion Criteria:

- Twin pregnancies.

- Obstetric pathologies that require immediate termination of pregnancy (severe preeclampsia, abruptio placenta, cord prolapse).

- Termination of pregnancy (whatever the reason) before complete corticoid treatment.

- Incomplete recollection of all data required for analysis.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Panama Saint Thomas H Panama

Sponsors (1)

Lead Sponsor Collaborator
Saint Thomas Hospital, Panama

Country where clinical trial is conducted

Panama, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cesarean section rate Number of cases in each cohort that were interrupted by cesarean section due to fetal distress (evidence of cord dystocia). 5 months No
Secondary Perinatal mortality Number of perinatal deaths (ante, peri and postpartum until 28 days postpartum)in each cohort. 5 months No
Secondary Neonatal sepsis Number of cases of neonates diagnosed with sepsis in each cohort. 5 months No